Britain's leading pharma company AstraZeneca, which has provided the vaccine worldwide during the Covid pandemic, has started recalling it from the market. Many complaints of blood clotting and low platelet count have been registered against its vaccine 'Vaxjaveria'. However, the company has claimed in the statement that a new version of the vaccine is available, hence the old stock has started being ordered.
Serum Institute of India, in collaboration with AstraZeneca, had made 'Covishield' vaccine available in India. AstraZeneca developed the Covid-19 vaccine in collaboration with Oxford University. It was made available as Vaxjavria in Europe and Covishield in India.
The European Union (EU) drug regulator the European Medicines Agency issued a notice on Tuesday confirming that Vaxzevria is no longer authorized for use in the 27-member economic bloc.
The company had decided to recall the vaccine in March itself. It said the marketing authority is working with regulatory authorities around the world to seek the recall of Vaxzeveria.
The company has accepted side effects in rare cases: According to global media reports, earlier AstraZeneca had admitted that its COVID-19 vaccine could cause side effects in rare cases. Which is called thrombosis with thrombocytopenia syndrome (TTS). More than 2.20 billion doses of COVID-19 vaccines have been administered in India and the majority of them were Covishield. Some people have also complained about the side effects of Covishield.
More than three billion doses are supplied globally
The company said that according to independent estimates, more than 65 lakh lives were saved in the first year of use alone, and more than three billion doses were supplied globally. That said, our efforts have been recognized by governments around the world and are widely recognized as a critical component of ending the global pandemic. Many cases are going on in the British court regarding the side effects of AstraZeneca.
Stop supply in December 2021 itself
Pune-based Serum Institute of India (SII) on Wednesday said it had stopped manufacturing and supplying additional doses of Covishield in December 2021. AstraZeneca has voluntarily withdrawn "marketing". Its Covid vaccine, sold as Covishield in India and Vaxjavria in Europe, has been approved.
The countdown to the Union Budget 2026-27 has begun. As always, the central government is likely
India-Bangladesh relations have been going through a rough patch since the ouster of Sheikh Hasin
Prime Minister Modi, in his address before the Economic Survey, said that it is natural for the c
'Even his flop film earns 200 crores...', Suniel Shetty gave such a reply on Salman Khan's failure.
Salman Khan, who has given blockbuster films like Bajrangi Bhaijaan, Sultan, and Ek Tha Tiger, ha
Boney Kapoor's daughter and Arjun Kapoor's sister, Anshula Kapoor, is one of the famous star kids
The Supreme Court is hearing a petition filed by the Enforcement Directorate (ED) against West Be
'Supreme' hearing on the arrest of Sonam Wangchuk today, wife filed a petition
Sonam Wangchuk was arrested by the government after the violence in Leh. Sonam Wangchuk is curren
Ebrahim Raisi: 'Can't rule out any possibility', foreign affairs expert on raisi's death
Iranian President Ebrahim Raisi was returning from East Azerbaijan. Then his helicopter crashed&n
The teams of India and Pakistan are once again in the headlines, as both teams are going to face
Rajasthan Royals and Delhi Capitals will try to forget their defeat in the last match and make a
